Jolla Pharmaceutical Co La serves as Executive at TETRAPHASE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Jolla Pharmaceutical Co La has executed 2 insider transactions totaling $8.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 28, 2020 involved purchasing 3,737,360 shares valued at $7.5M.
Jolla Pharmaceutical Co La currently holds 4,822,360 shares of TETRAPHASE PHARMACEUTICALS INC (TTPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jolla Pharmaceutical Co La has been a net buyer of TTPH stock. They have purchased $8.1M and sold $0 worth of shares.
Jolla Pharmaceutical Co La's most recent insider trade was on Jul 28, 2020, when they purchased 3,737,360 shares at $2.00 per share.
Get notified when new Form 4 filings are submitted
| $2.62 |
| Discretionary |